116 related articles for article (PubMed ID: 9347369)
1. Propofol in patients needing long-term sedation in intensive care: an assessment of the development of tolerance. A pilot study.
Buckley PM
Intensive Care Med; 1997 Sep; 23(9):969-74. PubMed ID: 9347369
[TBL] [Abstract][Full Text] [Related]
2. [Analgo-sedation in intensive care: a quantitative, EEG-based trial with propofol 1% and 2%].
Albrecht S; Ihmsen H; Suchodolski K; Frenkel C; Schüttler J
Anaesthesist; 1999 Nov; 48(11):794-801. PubMed ID: 10631438
[TBL] [Abstract][Full Text] [Related]
3. Use of 2% propofol to produce diurnal sedation in critically ill patients.
McLeod G; Wallis C; Dick J; Cox C; Patterson A; Colvin J
Intensive Care Med; 1997 Apr; 23(4):428-34. PubMed ID: 9142583
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of propofol/alfentanil infusions for sedation in ICU patients.
Frenkel C; Schuttler J; Ihmsen H; Heye H; Rommelsheim K
Intensive Care Med; 1995 Dec; 21(12):981-8. PubMed ID: 8750122
[TBL] [Abstract][Full Text] [Related]
6. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions.
Venn RM; Grounds RM
Br J Anaesth; 2001 Nov; 87(5):684-90. PubMed ID: 11878517
[TBL] [Abstract][Full Text] [Related]
7. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit.
Venn M; Newman J; Grounds M
Intensive Care Med; 2003 Feb; 29(2):201-7. PubMed ID: 12594584
[TBL] [Abstract][Full Text] [Related]
8. A randomized, open-label study of the safety and tolerability of fospropofol for patients requiring intubation and mechanical ventilation in the intensive care unit.
Candiotti KA; Gan TJ; Young C; Bekker A; Sum-Ping ST; Kahn R; Lebowitz P; Littman JJ
Anesth Analg; 2011 Sep; 113(3):550-6. PubMed ID: 21596879
[TBL] [Abstract][Full Text] [Related]
9. Bispectral index as a guide for titration of propofol during procedural sedation among children.
Powers KS; Nazarian EB; Tapyrik SA; Kohli SM; Yin H; van der Jagt EW; Sullivan JS; Rubenstein JS
Pediatrics; 2005 Jun; 115(6):1666-74. PubMed ID: 15930231
[TBL] [Abstract][Full Text] [Related]
10. Trace element homeostasis during continuous sedation with propofol containing EDTA versus other sedatives in critically ill patients.
Higgins TL; Murray M; Kett DH; Fulda G; Kramer KM; Gelmont D; Dedhia HV; Levy H; Teres D; Zaloga GP; Ko H; Thompson KA
Intensive Care Med; 2000; 26 Suppl 4():S413-21. PubMed ID: 11310904
[TBL] [Abstract][Full Text] [Related]
11. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs.
Barrientos-Vega R; Mar Sánchez-Soria M; Morales-García C; Robas-Gómez A; Cuena-Boy R; Ayensa-Rincon A
Crit Care Med; 1997 Jan; 25(1):33-40. PubMed ID: 8989173
[TBL] [Abstract][Full Text] [Related]
12. Propofol 2% in critically ill patients: effect on lipids.
McLeod G; Dick J; Wallis C; Patterson A; Cox C; Colvin J
Crit Care Med; 1997 Dec; 25(12):1976-81. PubMed ID: 9403745
[TBL] [Abstract][Full Text] [Related]
13. Use of alfentanil and propofol for outpatient monitored anesthesia care: determining the optimal dosing regimen.
Avramov MN; White PF
Anesth Analg; 1997 Sep; 85(3):566-72. PubMed ID: 9296410
[TBL] [Abstract][Full Text] [Related]
14. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial.
Chamorro C; de Latorre FJ; Montero A; Sánchez-Izquierdo JA; Jareño A; Moreno JA; Gonzalez E; Barrios M; Carpintero JL; Martín-Santos F; Otero B; Ginestal R
Crit Care Med; 1996 Jun; 24(6):932-9. PubMed ID: 8681594
[TBL] [Abstract][Full Text] [Related]
16. Intravenous infusion of low dose propofol for conscious sedation in cesarean section before spinal anesthesia.
Cheng YJ; Wang YP; Fan SZ; Liu CC
Acta Anaesthesiol Sin; 1997 Jun; 35(2):79-84. PubMed ID: 9293647
[TBL] [Abstract][Full Text] [Related]
17. Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation.
Fulton B; Sorkin EM
Drugs; 1995 Oct; 50(4):636-57. PubMed ID: 8536552
[TBL] [Abstract][Full Text] [Related]
18. Long-term continuous infusion of propofol as a means of sedation for patients in intensive care unit: relationship between dosage and serum concentration.
Wang SH; Hsu KY; Uang YS
Acta Anaesthesiol Sin; 1998 Jun; 36(2):93-8. PubMed ID: 9816719
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetically based propofol dosing strategy for sedation of the critically ill, mechanically ventilated pediatric patient.
Reed MD; Yamashita TS; Marx CM; Myers CM; Blumer JL
Crit Care Med; 1996 Sep; 24(9):1473-81. PubMed ID: 8797618
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to propofol's sedative effect in mechanically ventilated Rabbits.
Ypsilantis P; Mikroulis D; Politou M; Tsoukali H; Pitiakoudis M; Didilis V; Theodoridis G; Bougioukas G; Simopoulos C
Anesth Analg; 2006 Aug; 103(2):359-65, table of contents. PubMed ID: 16861417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
